ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet


















UK to expand NHS Subscription Pilot! Consultation Period launches
News from Davos 2020: Some positive signs, but overall a fragile antibiotic market at a tipping point
Developing systemic & inhaled antibiotics for lung infections
Push! Pull! Push! Pull! / Highlights from Davos 2018
Lessons in Discovery from Lynn Silver + Pro-con on alternatives to antibiotics
In Praise of Non-Inferiority
FDA analysis of 40-years of antibacterial development: Dheman et al.
Global survey of novel antibiotic reimbursement models / PASTEUR Act introduced to US House
Reimbursing for innovative antibiotics / Encouraging updates from the AMR conference
Categories of resistance: MDR, XDR, PDR, UDR, and (new!) DTR
Plazomicin (Achaogen) financial post-mortem: #PassPASTEUR
Mirror Bacteria: An AMR threat of unprecedented magnitude
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet

The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet